These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32575583)

  • 21. Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis.
    DeCarlo AA; Windsor LJ; Bodden MK; Harber GJ; Birkedal-Hansen B; Birkedal-Hansen H
    J Dent Res; 1997 Jun; 76(6):1260-70. PubMed ID: 9168859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14.
    de Veer SJ; Swedberg JE; Parker EA; Harris JM
    Biol Chem; 2012 Apr; 393(5):331-41. PubMed ID: 22505516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
    Nie J; Pei D
    Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14.
    Borgoño CA; Michael IP; Shaw JL; Luo LY; Ghosh MC; Soosaipillai A; Grass L; Katsaros D; Diamandis EP
    J Biol Chem; 2007 Jan; 282(4):2405-22. PubMed ID: 17110383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
    Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
    Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
    Sato H; Okada Y; Seiki M
    Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of human matrix metalloproteinases by various bacterial proteinases.
    Okamoto T; Akaike T; Suga M; Tanase S; Horie H; Miyajima S; Ando M; Ichinose Y; Maeda H
    J Biol Chem; 1997 Feb; 272(9):6059-66. PubMed ID: 9038230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.
    Miyamori H; Takino T; Kobayashi Y; Tokai H; Itoh Y; Seiki M; Sato H
    J Biol Chem; 2001 Jul; 276(30):28204-11. PubMed ID: 11382769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation profiles and regulatory cascades of the human kallikrein-related peptidases.
    Yoon H; Laxmikanthan G; Lee J; Blaber SI; Rodriguez A; Kogot JM; Scarisbrick IA; Blaber M
    J Biol Chem; 2007 Nov; 282(44):31852-64. PubMed ID: 17823117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of membrane type-matrix metalloproteinases.
    Hernandez-Barrantes S; Bernardo M; Toth M; Fridman R
    Semin Cancer Biol; 2002 Apr; 12(2):131-8. PubMed ID: 12027585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
    Zhou J; Windsor LJ
    J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteinase-activated receptors (PARs): differential signalling by kallikrein-related peptidases KLK8 and KLK14.
    Ramachandran R; Eissa A; Mihara K; Oikonomopoulou K; Saifeddine M; Renaux B; Diamandis E; Hollenberg MD
    Biol Chem; 2012 Apr; 393(5):421-7. PubMed ID: 22505524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
    Stack MS; Itoh Y; Young TN; Nagase H
    Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.
    Knäuper V; Bailey L; Worley JR; Soloway P; Patterson ML; Murphy G
    FEBS Lett; 2002 Dec; 532(1-2):127-30. PubMed ID: 12459476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic Kallikrein 14 Mice Display Major Hair Shaft Defects Associated with Desmoglein 3 and 4 Degradation, Abnormal Epidermal Differentiation, and IL-36 Signature.
    Gouin O; Barbieux C; Leturcq F; Bonnet des Claustres M; Petrova E; Hovnanian A
    J Invest Dermatol; 2020 Jun; 140(6):1184-1194. PubMed ID: 32169475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MT1-MMP association with membrane lipid rafts facilitates G-CSF--induced hematopoietic stem/progenitor cell mobilization.
    Shirvaikar N; Marquez-Curtis LA; Shaw AR; Turner AR; Janowska-Wieczorek A
    Exp Hematol; 2010 Sep; 38(9):823-35. PubMed ID: 20471446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
    Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
    Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.
    Minond D; Lauer-Fields JL; Cudic M; Overall CM; Pei D; Brew K; Moss ML; Fields GB
    Biochemistry; 2007 Mar; 46(12):3724-33. PubMed ID: 17338550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caveolin-1 inhibits membrane-type 1 matrix metalloproteinase activity.
    Kim HN; Chung HS
    BMB Rep; 2008 Dec; 41(12):858-62. PubMed ID: 19123976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.